BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 27625082)

  • 1. Olmesartan Reduces New-onset Atrial Fibrillation and Atrial Fibrillation Burden after Dual-chamber Pacemaker Implantation in Atrioventricular Block Patients.
    Zhang H; Pan C; Zhang J; Zhu LL; Huang K; Zhong Y; Hu ZY
    Chin Med J (Engl); 2016 Sep; 129(18):2143-8. PubMed ID: 27625082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of atrial preference pacing on atrial fibrillation electrophysiological substrate in Myotonic Dystrophy type 1 population.
    Russo V; Nigro G; DI Meo F; Papa AA; Cioppa ND; Proietti R; Russo MG; Calabrò R; Politano L
    Acta Myol; 2014 Dec; 33(3):127-35. PubMed ID: 25873781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atrial fibrillation before and after pacemaker implantation (WI and DDD) in patients with complete atrioventricular block].
    Matusik P; Woznica N; Lelakowsk J
    Pol Merkur Lekarski; 2010 May; 28(167):345-9. PubMed ID: 20568394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial.
    Goette A; Schön N; Kirchhof P; Breithardt G; Fetsch T; Häusler KG; Klein HU; Steinbeck G; Wegscheider K; Meinertz T
    Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):43-51. PubMed ID: 22157519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Left atrial and ventricular epicardial dual chamber pacing through a left lateral thoracotomy to treat pediatric complete atrioventricular block].
    Li XM; Zhang Y; Pan GY; Liu HJ; Li HY; Wu QY
    Zhonghua Er Ke Za Zhi; 2013 Aug; 51(8):578-83. PubMed ID: 24225287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors of new-onset atrial fibrillation after pacemaker implantation.
    Wu Z; Chen X; Ge J; Su Y
    Herz; 2021 Apr; 46(Suppl 1):61-68. PubMed ID: 32107563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of unnecessary right ventricular pacing by managed ventricular pacing and search AV+ algorithms in pacemaker patients: 12-month follow-up results of a randomized study.
    Chen S; Chen K; Tao Q; Zheng L; Shen F; Wu S; Fan J; Xu G; Wang L; Zhou X; Zhang S;
    Europace; 2014 Nov; 16(11):1595-602. PubMed ID: 24706091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The development of AF over time in patients with permanent pacemakers: objective assessment with pacemaker diagnostics demonstrates distinct patterns of AF.
    Sugihara C; Veasey R; Freemantle N; Podd S; Furniss S; Sulke N
    Europace; 2015 Jun; 17(6):864-70. PubMed ID: 26023175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological determinants of atrial fibrillation in sinus node dysfunction despite atrial pacing.
    De Sisti A; Attuel P; Manot S; Fiorello P; Halimi F; Leclercq JF
    Europace; 2000 Oct; 2(4):304-11. PubMed ID: 11194597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between right ventricular pacing and atrial fibrillation burden and disease progression in patients with paroxysmal atrial fibrillation: the long-MinVPACE study.
    Veasey RA; Arya A; Silberbauer J; Sharma V; Lloyd GW; Patel NR; Sulke AN
    Europace; 2011 Jun; 13(6):815-20. PubMed ID: 21208945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of atrial fibrillation during right ventricular pacing.
    Pastore G; Zanon F; Baracca E; Aggio S; Corbucci G; Boaretto G; Roncon L; Noventa F; Barold SS
    Europace; 2016 Mar; 18(3):353-8. PubMed ID: 26443444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
    Ezekowitz MD; Ellenbogen KA; DiMarco JP; Kaszala K; Boddy A; Geba GP; Koren A
    J Interv Card Electrophysiol; 2015 Mar; 42(2):69-76. PubMed ID: 25638303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.
    Kantharia BK; Freedman RA; Hoekenga D; Tomassoni G; Worley S; Sorrentino R; Steinhaus D; Wolkowicz JM; Syed ZA;
    Europace; 2007 Nov; 9(11):1024-30. PubMed ID: 17913697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a pacing mode preserving spontaneous AV conduction on ventricular pacing burden and atrial arrhythmias.
    Rey JL; Quenum S; Hero M
    Pacing Clin Electrophysiol; 2012 May; 35(5):580-5. PubMed ID: 22339661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter, prospective, randomized safety and efficacy study of a new atrial-based managed ventricular pacing mode (MVP) in dual chamber ICDs.
    Sweeney MO; Ellenbogen KA; Casavant D; Betzold R; Sheldon T; Tang F; Mueller M; Lingle J;
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):811-7. PubMed ID: 16101620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT).
    Carlson MD; Ip J; Messenger J; Beau S; Kalbfleisch S; Gervais P; Cameron DA; Duran A; Val-Mejias J; Mackall J; Gold M;
    J Am Coll Cardiol; 2003 Aug; 42(4):627-33. PubMed ID: 12932592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Atrial flutter and atrial fibrillation by DDD stimulation].
    Fröhlig G; Sen S; Rettig G; Schieffer H; Bette L
    Z Kardiol; 1985 Sep; 74(9):537-47. PubMed ID: 4060830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Safety and effectiveness of dual chamber pacing in patients over 80 years of age with previous episodes of paroxysmal atrial fibrillation].
    Hrovatin E; Zardo F; Brieda M; Dametto E; Sparacino L; Antonini-Canterin F; Burelli C; Huang G; Nicolosi GL
    Ital Heart J Suppl; 2002 Oct; 3(10):1027-33. PubMed ID: 12478829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent atrial fibrillation is associated with a poor prognosis in patients with atrioventricular block and dual-chamber pacemaker.
    Petrač D; Radeljić V; Delić-Brkljačić D; Manola Š; Cindrić-Bogdan G; Pavlović N
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):695-702. PubMed ID: 22452373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, echocardiographic, and pacing parameters affecting atrial fibrillation burden in patients with tachycardia-bradycardia syndrome.
    Ciszewski JB; Chwyczko T; Kowalik I; Majda W; Farkowski MM; Jankowska A; Borowiec A; Syska P; Szwed H; Pytkowski M
    Kardiol Pol; 2018; 76(2):338-346. PubMed ID: 29131294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.